Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ACTRN12611000999932Phase 4Completed
Phase 4, open-label, single-arm trial of artesunate and amodiaquine in Malaria, sponsored by Malaria Sub-directorate, Ministry of Health Indonesia. Primary endpoints: Percentage of treatment failures and Percentage of adverse events. Started Dec 2011; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ACTRN12611000999932.